CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran

Background: Exposure to endogenous hormones such as estrogen is known as a lifetime Breast Cancer (BC) risk factor. Polymorphisms in genes that are involved in the steroidogenic process, such as Cytochrome P450c17alpha (CYP17), affect individuals’ susceptibility to BC. In Iran, the highest incident...

Full description

Bibliographic Details
Main Authors: Elmira EBRAHIMI, Tayebeh SABOKBAR, Sharareh ESKANDARIEH, Vahideh PEYGHAMBARI, Reza SHIRKOOHI
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2017-04-01
Series:Iranian Journal of Public Health
Subjects:
Online Access:https://ijph.tums.ac.ir/index.php/ijph/article/view/9764
_version_ 1818321243638595584
author Elmira EBRAHIMI
Tayebeh SABOKBAR
Sharareh ESKANDARIEH
Vahideh PEYGHAMBARI
Reza SHIRKOOHI
author_facet Elmira EBRAHIMI
Tayebeh SABOKBAR
Sharareh ESKANDARIEH
Vahideh PEYGHAMBARI
Reza SHIRKOOHI
author_sort Elmira EBRAHIMI
collection DOAJ
description Background: Exposure to endogenous hormones such as estrogen is known as a lifetime Breast Cancer (BC) risk factor. Polymorphisms in genes that are involved in the steroidogenic process, such as Cytochrome P450c17alpha (CYP17), affect individuals’ susceptibility to BC. In Iran, the highest incident of BC is among young women. This study aimed to find prevalence of Single Nucleotide Polymorphisms (SNPs) in genes such as CYP17 and significant correlation with age-oriented group of breast cancer. Methods: In 2016, a case series study was conducted on a total population of 205 patients suffering from breast cancer referred to Cancer Institute, Imam Khomeini Hospital Complex, Tehran, Iran. This population consisted of 104 cases less than 40 yr old and 101 cases over 40. The genotype variants of CYP17 MspA1 were determined using PCR, followed by RFLP. The association of CYP17 MspA1 polymorphisms with the risk of BC in two different age groups was evaluated by calculating odds ratio and 95% confidence intervals using unconditional logistic regression. Results: Carriers of at least one A2 allele may have higher risk of developing breast cancer at younger age compared to patients with A1/A1 genotype (Odds Ratio: 1.99, 95% Confidence Interval: 1.11-3.57, P=0.02). Conclusion: CYP17gene polymorphisms may have influence on the early onset of breast cancer.
first_indexed 2024-12-13T10:37:49Z
format Article
id doaj.art-ee1b107b518841a0976eacf6190a6155
institution Directory Open Access Journal
issn 2251-6085
2251-6093
language English
last_indexed 2024-12-13T10:37:49Z
publishDate 2017-04-01
publisher Tehran University of Medical Sciences
record_format Article
series Iranian Journal of Public Health
spelling doaj.art-ee1b107b518841a0976eacf6190a61552022-12-21T23:50:41ZengTehran University of Medical SciencesIranian Journal of Public Health2251-60852251-60932017-04-01464CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of IranElmira EBRAHIMI0Tayebeh SABOKBAR1Sharareh ESKANDARIEH2Vahideh PEYGHAMBARI3Reza SHIRKOOHI4Group of Genetics, Cancer Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, IranGroup of Genetics, Cancer Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran AND Neurology & Neurosciences Research Center, Qom University of Medical Sciences, Qom, IranBrain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran AND MS Research Center, Neurosciences Institute, Tehran University of Medical Sciences, Tehran, IranGroup of Genetics, Cancer Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, IranGroup of Genetics, Cancer Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, IranBackground: Exposure to endogenous hormones such as estrogen is known as a lifetime Breast Cancer (BC) risk factor. Polymorphisms in genes that are involved in the steroidogenic process, such as Cytochrome P450c17alpha (CYP17), affect individuals’ susceptibility to BC. In Iran, the highest incident of BC is among young women. This study aimed to find prevalence of Single Nucleotide Polymorphisms (SNPs) in genes such as CYP17 and significant correlation with age-oriented group of breast cancer. Methods: In 2016, a case series study was conducted on a total population of 205 patients suffering from breast cancer referred to Cancer Institute, Imam Khomeini Hospital Complex, Tehran, Iran. This population consisted of 104 cases less than 40 yr old and 101 cases over 40. The genotype variants of CYP17 MspA1 were determined using PCR, followed by RFLP. The association of CYP17 MspA1 polymorphisms with the risk of BC in two different age groups was evaluated by calculating odds ratio and 95% confidence intervals using unconditional logistic regression. Results: Carriers of at least one A2 allele may have higher risk of developing breast cancer at younger age compared to patients with A1/A1 genotype (Odds Ratio: 1.99, 95% Confidence Interval: 1.11-3.57, P=0.02). Conclusion: CYP17gene polymorphisms may have influence on the early onset of breast cancer.https://ijph.tums.ac.ir/index.php/ijph/article/view/9764Breast cancerCYP17 geneEarly onset breast cancerEstrogenLate-onset breast cancer
spellingShingle Elmira EBRAHIMI
Tayebeh SABOKBAR
Sharareh ESKANDARIEH
Vahideh PEYGHAMBARI
Reza SHIRKOOHI
CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran
Iranian Journal of Public Health
Breast cancer
CYP17 gene
Early onset breast cancer
Estrogen
Late-onset breast cancer
title CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran
title_full CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran
title_fullStr CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran
title_full_unstemmed CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran
title_short CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran
title_sort cyp17 mspa1 gene polymorphism and breast cancer patients according to age of onset in cancer institute of iran
topic Breast cancer
CYP17 gene
Early onset breast cancer
Estrogen
Late-onset breast cancer
url https://ijph.tums.ac.ir/index.php/ijph/article/view/9764
work_keys_str_mv AT elmiraebrahimi cyp17mspa1genepolymorphismandbreastcancerpatientsaccordingtoageofonsetincancerinstituteofiran
AT tayebehsabokbar cyp17mspa1genepolymorphismandbreastcancerpatientsaccordingtoageofonsetincancerinstituteofiran
AT sharareheskandarieh cyp17mspa1genepolymorphismandbreastcancerpatientsaccordingtoageofonsetincancerinstituteofiran
AT vahidehpeyghambari cyp17mspa1genepolymorphismandbreastcancerpatientsaccordingtoageofonsetincancerinstituteofiran
AT rezashirkoohi cyp17mspa1genepolymorphismandbreastcancerpatientsaccordingtoageofonsetincancerinstituteofiran